Matt Ferguson is a Senior Principal Investigator within Product Development for inhalation programs at Lonza’s site in Bend, Oregon, USA. He joined Lonza in 2020 and has more than 17 years of experience in the pharmaceutical industry, focusing on product development and inhalation technologies, including engineered particles, novel device design, and dry-powder inhaler (DPI) formulations. Prior to joining Lonza, Matt worked Catalent Pharma Solutions, GlaxoSmithKline, and Cirrus Pharmaceuticals, in positions of increasing authority with oversight for product development, contract development and manufacturing organization (CDMO) functions, clinical supply, and Quality Control. Matt received his B.S. in Chemistry from North Carolina State University.